The company have significantly improved its progress of a new solution for cardiac amyloidosis, employing the compound. Initial patient results suggests promising improvements for patients affected by the serious https://bridgebio103056.pages10.com/company-progresses-cardiac-amyloidosis-therapy-with-the-drug-77581512